Targeting Gastrin-releasing Peptide in Neuroblastoma
The overall survival for neuroblastoma remains dismal, in part due to the emergence of resistance to chemotherapeutic drugs resulting in aggressive, refractory disease. As a neuroendocrine tumor, neuroblastomas secrete a number of peptides; one such being the gastrin-releasing peptide (GRP). GRP ant...
| Main Author: | |
|---|---|
| Other Authors: | |
| Format: | Others |
| Language: | en |
| Published: |
VANDERBILT
2013
|
| Subjects: | |
| Online Access: | http://etd.library.vanderbilt.edu/available/etd-08202013-144426/ |